Previous close | 0.6000 |
Open | 0.6500 |
Bid | 0.0000 |
Ask | 1.3500 |
Strike | 2.00 |
Expiry date | 2024-05-17 |
Day's range | 0.6500 - 0.6500 |
Contract range | N/A |
Volume | |
Open interest | 198 |
VIENNA, Va., May 16, 2024--CEL-SCI Corporation reports second quarter fiscal 2024 financial results.
VIENNA, Va., May 08, 2024--CEL-SCI receives FDA go-ahead for its confirmatory study of Multikine in the treatment of head & neck cancer.
VIENNA, Va., April 23, 2024--CEL-SCI appoints Mario Gobbo to its Board of Directors.